Carter Todd Alfred 4
4 · Voyager Therapeutics, Inc. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Carter Todd Alfred
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-01-17$7.18/sh−1,266$9,090→ 53,094 total
Footnotes (2)
- [F1]Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 13, 2024. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.04 to $7.27, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.